Showing results (1701-1710 of 3,793) with videos related to

Sort By:
Pageof 380
Oncoimmunology|May 4, 2018
Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancerEtienne Giroux Leprieur, Guillaume Herbretau, Coraline Dumenil, et al.
Oncoimmunology|May 4, 2018
Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation and response to chemotherapeutic drugsKawaljit Kaur, Paytsar Topchyan, Anna Karolina Kozlowska, et al.
Oncoimmunology|June 23, 2017
Novel anti-myeloma immunotherapies targeting the SLAM family of receptorsSabarinath Venniyil Radhakrishnan, Neelam Bhardwaj, Tim Luetkens, et al.
Oncoimmunology|June 23, 2017
Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplantSami B Kanaan, Hilary S Gammill, Whitney E Harrington, et al.
Oncoimmunology|June 23, 2017
Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptorElizabeth L McMichael, Nicholas B Courtney, Megan C Duggan, et al.
Oncoimmunology|May 17, 2017
Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapyJun Ren, William R Gwin, Xinna Zhou, et al.
Oncoimmunology|May 17, 2017
The mutational status of p53 can influence its recognition by human T-cellsKaterina Shamalov, Shlomo N Levy, Miryam Horovitz-Fried, et al.
Oncoimmunology|May 17, 2017
Composite biomarkers defined by multiparametric immunofluorescence analysis identify ALK-positive adenocarcinoma as a potential target for immunotherapyHélène Roussel, Eléonore De Guillebon, Lucie Biard, et al.
Oncoimmunology|May 17, 2017
Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytesEva M García-Cuesta, Gloria Esteso, Omodele Ashiru, et al.
Oncoimmunology|May 17, 2017
The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?Christine Böger, Hans-Michael Behrens, Sandra Krüger, et al.
Pageof 380